Trials / Unknown
UnknownNCT04234932
Short-term Effect of Rho-kinase Inhibitor on Retinal Circulation
- Status
- Unknown
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 10 (estimated)
- Sponsor
- University of the Incarnate Word · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Investigate changes in optical coherence tomography angiography of the optic nerve and macula following topical instillation of commercial preparations of netarsudil 0.02% ophthalmic solution.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Netarsudil Ophthalmic | Topical instillation of commercial preparations of netarsudil 0.02% ophthalmic solution (Rhopressa and Roclatan) |
Timeline
- Start date
- 2020-01-06
- Primary completion
- 2021-01-01
- Completion
- 2021-01-01
- First posted
- 2020-01-21
- Last updated
- 2020-04-14
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04234932. Inclusion in this directory is not an endorsement.